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2Abstract20
The purpose here was to determine the problems cat owners encounter in medicating21
their cats with orally administered drugs at home. The study was carried out as an open e-22
questionnaire survey addressed to cat owners in which we focused on the oral administration23
route. A total of 46 completed questionnaires were included in the survey. In the study, 4624
cats received 67 orally administered drugs. Approximately half of the drugs were registered25
for use in cats by the European Medicines Agency (54%), and there were also off-label drugs26
registered for human (36%) and canine medication (7.4%) and an ex tempore drug (3.0%).27
The owners were unable to give the doses as prescribed for their cats for one fourth of the28
medications (16/67). Drugs that were registered for feline medication were significantly more29
palatable than drugs registered for other species (odds ratio (OR) 4.9), and liquid formulations30
were significantly more palatable than solid formulations (OR 4.8). However, most of the31
owners (22/38) preferred a solid dosage form, while few (4/38) chose a liquid formulation.32
The results indicate that there is still a need for more palatable and easily administered oral33
drugs for cats.34
35
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3Introduction37
Cats are popular as companion animals and are generally well cared for throughout38
their lifespan. Owners are willing to provide their cats with good health care and medication39
for illnesses on veterinarians’ recommendations (Jevring, 2005). However, owners often40
express difficulty in medicating their pets.41
42
Medication compliance in companion animals may be compared with that in43
paediatrics, since owners and parents are responsible for medicating the patient (Grave and44
Tanem, 1999). All medications face similar challenges, such as the patient often being45
reluctant to take the drug, due to unpleasant taste and a high degree of noncompliance46
(Matsui, 1997; Haynes et. al., 2002). In veterinary medication, owners may prefer oral solid47
dosage forms, such as tablets, for long-term administration because they are familiar with48
how to administer these dosage forms to the pet (Khor et al., 2012). A choice of palatable49
formulations may increase pet acceptance (Thombre, 2004). Nevertheless, the degree of50
compliance varies widely. In compliance studies in dogs, 27-84% of the medications were51
given as prescribed (Bomzon, 1978; Grave and Tanem, 1999; Adams et al., 2005). In many52
cases the reason for non-compliance was that the owner was unable to follow the dosing53
regimen, rather than the dog’s resistance to medication. The owners’ medication experiences,54
as well as animal habituation in medication, also affect compliance. Compliance is clearly a55
multifaceted issue, in which the owners’ abilities to follow the medication instructions play an56
important role (AAHA, 2003). Thus, pet compliance can be evaluated indirectly through57
owner consumption success or as the free-choice acceptance of the drug by the pet.58
59
Few results are available on medication compliance in cats. Cats are more difficult to60
medicate than dogs, due to their discriminating nature (Thombre, 2004). They can be less61
4accustomed to being restrained than dogs and may display fear or resistance when medicated.62
The free-choice acceptability in cats is typically less than 50% for conventionally flavoured63
tablets (Ahmed and Kasraian, 2002). Various methods for administering oral solid dosage64
forms to cats have been used, such as forcing the animal to swallow a tablet (‘dry65
swallowing’) by placing it in the back of the oral cavity with the fingers or by a specific66
device, hiding the tablet in a highly palatable food or treat, and liquefying or crushing the67
tablet (Thombre, 2004; Bennett et al., 2010). Consumption success has rarely been evaluated68
in cats. For bitter-tasting drugs, owner-estimated consumption success rates have been as high69
as 90% for conventional tablets (dry swallowing) and 93% for extemporaneously prepared70
flavoured suspensions (Khor et al., 2012). In another study, dissolving oral film strips were71
easier to administer than gelatin capsules (Traas et al., 2010). Dosage form palatability has72
been assessed in studies in association with drug efficacy evaluations (Ahmed and Kasraian,73
2002; Gunew et al., 2008; Giraudel et al., 2010). In general, flavoured formulations (liquids74
or solids) are more palatable than conventional tablets, but comparison between studies is75
difficult, because various criteria for acceptance have been used. The criteria for determining76
palatability have been clarified quite recently by European Medicines Agency (EMA, 2014).77
78
The aim here was to determine the difficulties cat owners encounter in administering79
oral medication to their pets. Information is needed for developing palatable formulations for80
cats, as well as the methodology for assessment of acceptance. Detailed knowledge also81
supports veterinarians in counselling owners. More specifically, the purpose was to evaluate82
the palatability of dosage forms (expressed as free-choice acceptance), ease of administration83
of the dosage forms and ease in following the medication schedules (owner compliance). The84
hypothesis was that a marked number of owners experience difficulty with one or more of85
these aspects in medicating their cats at home.86
5Materials and methods87
Study outline88
The study was carried out as an open e-questionnaire survey addressed to cat owners89
responsible for medicating their cats at home. The platform chosen was a secured online tool90
provided by the University of Helsinki (e-form). The term compliance was adopted, as91
described by Cramer et al. (2008), in which the medication compliance (synonym adherence)92
refers to the degree or extent of conformity to the recommendations for daily treatment by the93
provider with respect to the timing, dosage and frequency. The theoretical framework of the94
“five interacting dimensions of adherence” (Sabaté, 2003) was implemented in exploring the95
study aims, and the e-questionnaire was adopted within the context of veterinary medication.96
97
The questionnaire was developed in collaboration with veterinarians and pharmacists98
(seven specialists, University of Helsinki). In developing the questionnaire, we focused on the99
five dimensions of adherence and especially on the therapy-related factors, such as the100
medical regimen, ease in following the regimen and ease in administration of the dosage form101
to the cat. Pet compliance was also evaluated as free-choice acceptance of the drug by the cat.102
Originally, the oral, topical, eye and ear administration routes were included, but in this study103
we focused on orally administered dosage forms, since it is a common route of104
administration. The drugs were categorized according to their target species registration;105
feline, canine or other (human medication or ex tempore drugs).106
107
The Viikki Campus Research Ethics Committee (University of Helsinki) approved the108
study protocol (Statement of Approval 14.1.2010). In a pilot study, preliminary suggestions109
by 14 cat owners resulted in rewording of one background question and of the instructions for110
answering the questions. The Checklist for Reporting Results of Internet E-Surveys111
6(CHERRIES) (Eysenbach, 2004) was followed in reporting the results of the e-questionnaire112
survey.113
114
Recruitment of cat owners115
Owners who had medicated their cats were recruited from the Veterinary Teaching116
Hospital (University of Helsinki), four randomly chosen municipal clinics and four private117
veterinary clinics. One private cat clinic and the Veterinary Teaching Hospital were chosen118
without randomizing, due to the large numbers of their feline patients. The inclusion criteria119
for the cat owners was medication experience during the previous 3 months at home. The120
recruitment time span was 3 months.121
122
The clinics were informed of the study via telephone calls, cover letters and e-mails.123
In all, 840 invitation letters were sent to the clinics that were willing to participate. The124
invitation letters included information on the study for the cat owners to support their decision125
to participate, and an Internet link to the questionnaire. The letters were distributed among the126
personnel of the clinics. Additionally, notices were distributed at the University Pharmacy127
(Viikki) and at one boarding cattery. Cat owners were also recruited from four Internet cat-128
themed discussion forums. One notice was posted at the University Library (Viikki).129
Participation in the study was voluntary, and no material incentives were provided to the130
participants.131
132
Questionnaire133
Demographic data on the cats and their owners were collected (Table 1). The134
questions concerning the dosage form and administration of the drug are described in Table 2.135
A total of 46 completed questionnaires on 46 cats were included in the study. Each cat136
7received one or more drugs; in all, 67 orally administered drugs were included (Table 3).137
Three completed questionnaires on orally administered drugs were excluded, one because the138
owner lived abroad, another because the respondent was an employee of a rescue shelter and139
therefore not a regular cat owner and a third because the owner did not define the drug.140
Another 16 completed questionnaires were excluded, because the reported administration141
route was not oral. The clinics were asked to return the unused invitation letters; 447/850142
(53%) letters were returned.143
144
Statistical methods145
Descriptive statistics on the number of observations and percentage frequencies were146
presented. Statistical analyses were performed using SAS System for Windows, version 9.3147
(SAS Institute Inc., Cary, NC, USA). The outcome variables concerning the owner’s ability to148
give all the doses to the cat, free-choice acceptance of the drug, salivation, gagging or149
vomiting, following the medication schedule and ease in following the schedule were150
measured categorically, as were the explanatory variables (drug, dosage form, number of151
daily administrations, duration of medication, adverse effects). Frequency tables were152
constructed between the categories of the explanatory variables on all outcome variables. A153
cumulative logistic regression model was fitted to outcome variables that were evaluated154
through an agree-neutral-disagree-scale. The probabilities were modelled for responses155
having lower values (i.e. more agreement). Due to small cell frequencies, the original five-156
step Likert-scale (Strongly agree/Agree, Neither agree nor disagree, Disagree/ Strongly157
disagree) questions were transformed into three-class categorical variables, the middle class158
representing neutral, the lower and upper classes representing agreement and disagreement,159
respectively. The variable ‘Number of doses administered daily’ was transformed into a160
dichotomous variable (1 or less, more than 1). For the binary response ‘Ability to give all161
8doses’, a logistic regression model was fitted to the data, and the probability was modelled for162
the response value being ‘yes’. All explanatory variables were analysed separately. In all163
models the explanatory variable in question was included in the model as the sole fixed factor.164
The effect of the cat was included in the model as a random effect. For all analyses, the odds165
ratios (ORs) and their 95% confidence intervals (CIs) were constructed to describe the group166
differences.167
168
Results169
Dosage form and administration schedule170
Approximately half of the drugs were registered for use in cats by the EMA (Table 3).171
Most of these were solid dosage forms: tablets or capsules. Off-label drugs were registered for172
human (36%) or dog medication (7.4%) and one was an ex tempore tablet. All drugs were173
immediate-release formulations. In nearly half of the cases, the drug was used as long-term174
medication for chronic illnesses (Table 4). Most of the oral drugs were administered once or175
twice per day. However, the total administration frequency could have been higher if the cat176
had concurrent medications (orally administered or other routes of administration). This was177
the case for one third of the cats (n = 16). The maximum dosing requirement was five to six178
times per day.179
180
When asked “Did the cat accept the drug willingly?”, the owners agreed in 35% of181
the cases if the drug was registered for feline medication (Table 5). The free-choice182
acceptance was nearly five-fold higher (OR 4.9, P < 0.05) for drugs registered for cats than183
those registered for other species. A statistically significant relationship was also evident for184
the dosage form, with solutions and suspensions being more acceptable than tablets or185
capsules (OR 4.8). For the other questions, no statistically significant effects were observed186
9(Table 6). Most of the owners agreed that precisely following the medication schedule was187
easy.188
189
Dosage form and administration practice190
In only two cases did the cat willingly accept the drug by consuming it ‘as a treat’191
(Table 7).  Most of the drugs were introduced orally by dry swallowing (36/67). In addition,192
various methods for facilitating drug administration were described, such as mixing the drug193
in cat’s food or covered with a palatable treat. The cat either consumed the modified dosage194
form as such or else the form was introduced orally. It was also common practice for owners195
to first crush the tablet or dissolve it in water, after which the drug was mixed in the food or196
given by a syringe. If the package included an administration device, the owners found that197
using it was easy, and the guidance of the device was deemed adequate and clear (Table 8).198
199
Difficulties encountered in drug treatment200
No medications in which all the doses were missed were reported. However, some201
doses were missed in one fourth (n = 16) of the cases (Table 6). At most, four doses were202
missed for one prescribed drug (n = 8), and most of these cases were associated with short-203
term medication (n = 6). In general, the missed doses occurred at the beginning (n = 6) or in204
the middle (n = 2) of the course of medication. In response to the open question “Why could205
you not give all the doses to the cat?” (n = 15), most of the answers (n = 11) were associated206
with adverse effects or the individual behaviour of the cat; the cat spat the drug out (n = 5),207
vomited (n = 2), salivated strongly (n = 2) or resisted the medication (n = 2). For some208
owners, scanty medication experience made it difficult to administer the drug in the beginning209
(n = 2). Answers to the question “Why was it difficult to follow the medication schedule?” (n210
= 15) included adverse effects (n = 2) or some other feline response (n = 2), such as the drug211
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given with the food was not accepted, due to lack of appetite. One third of the responses were212
related to the owners’ working hours (n = 5) or, in the case of chronic illness, it was not213
always possible for the owner to commit to long-term medication (n = 2). One owner stopped214
the medication, because the symptoms disappeared, but then started it again after consulting215
the veterinarian.216
217
For the question, “What was the major problem related to the drug itself or218
administering the drug to the cat?”, 41 out of 46 responses were obtained. One fourth of the219
answers concerned the bad taste of the drug (n = 11). Other characteristics of the dosage form220
were also considered problematic; these included taking the right dose by splitting the tablet221
(n = 7), the tablet size being too large (n = 4) or the syringe for a liquid drug being a bit222
difficult to use (n = 1). Again, the individual behaviour of the cat and adverse effects were223
mentioned; the cat did not willingly take the drug, and the owner had to force it (n = 8) or the224
drug caused increased salivation or other side effects (n = 4). However, approximately half of225
the owners agreed with the question “Did the administration of the drug become easier over226
time?” (Table 8).227
228
Dosage form and administration preferences229
An open question “What kind of dosage form would you prefer in medicating your230
cat?” received 38 answers (38/46). A solid dosage form was the most preferred formulation;231
58% of the owners (n = 22) chose a tablet or capsule, while some also mentioned that the232
tablet should be small (n = 8), palatable (n = 2) or tasteless (n = 1). Four owners did not233
define the dosage form, only that the drug should be palatable or tasteless. Some (n = 3) chose234
either a solid or liquid formulation, if it were palatable enough, or a liquid or semisolid235
dosage form (n = 4). Few preferred injections (n = 2) or a pour-on formulation (n = 1).236
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The question “What would you consider to be the easiest method for administering the238
drug to your cat?” received 43 responses (43/46). Few (n = 3) answered that their cat239
consumed the drug willingly without any modification to the dosage form or administration240
aid. One third of the owners mentioned a solid dosage form by dry swallowing (n = 16). Some241
considered that the drug would be easiest to administer orally, but only after coating it with242
some palatable viscous material, such as butter (n = 4). In two cases, the owner specified that243
two persons would be needed to administer the drug orally. Some owners (n = 7) named244
liquids as the easiest dosage form; the drug should be either in a liquid form or the owner245
would dissolve a solid drug and then administer it orally with a syringe. For others, the easiest246
way was to give the drug hidden in the cat’s food or in a treat (n = 8). One owner mentioned247
that the cat should be hungry before medication, and one stated that the cat would lick a liquid248
drug from its fur. One considered injections as the easiest means of medication.249
250
Owner counselling supported drug treatment251
The owners considered themselves well informed about the medication (88%) (Table252
8). In an open question, however, owners reported that they would have liked to have more253
information on administration methods (n=2) or how to take the right dose from the package254
(n=1). One owner had hoped for more information on the active pharmaceutical ingredient255
(drug-drug interactions, adverse effects and if the drug was sufficiently efficacious) and the256
presence of generic products on the market. For the question “Did you read the drug257
description before administering the drug?”, the owners agreed in 85% of the cases.258
259
Discussion260
The hypothesis was that a marked number of owners experience difficulty in261
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medicating their cats at home. The owners were unable to give the doses as prescribed for one262
fourth of the medications (24%), and therefore the owner compliance and owner consumption263
success can be considered to be 76%. The data indicate that off-label use of drugs is still264
common in the feline setting, since almost half of the drugs used were off-label. Pet265
compliance expressed as free-choice acceptance was higher for feline formulations than for266
off-label drugs, yet only in 35 % of these feline formulations did the owner agree that the cat267
took the drug willingly. Solutions and suspensions were significantly more acceptable than268
solid dosage forms. It is noteworthy that these were practically all (excluding one off-label269
drug) feline medications in which the palatability issues were considered in formulation270
development by the pharmaceutical company. In other studies, oral suspensions registered for271
feline medication were also well accepted by cats, either given alone or mixed in food (Litster272
et al., 2007; Gunew et al., 2008). Product development for feline medication is apparently273
progressing in the right direction, although there is further need for drugs registered274
specifically for cats, based on the amount of off-label usage.275
276
Most consumption failures were related to the individual behaviour of the cat (the cat277
resisted the medication or spat the drug out) or adverse effects (such as strong salivation).278
Some failures may have been caused by the bad taste of the drug, which the owners presented279
as an important reason. Interestingly, the owners preferred tablets as a dosage form, although280
there was significantly better pet compliance with the liquids. In most cases, tablets were281
administered orally ‘dry swallowing’. Such preference may be explained by the owner being282
familiar with the administration technique (Khor et al., 2012). The ‘dry swallowing’ method283
applies when medicating cats with a compliant nature, but is problematic in cases in which284
the cat shows fear or resistance. In forcing, the cat may become even more unwilling to take285
the drug, which may negatively affect both the human animal relationship and owner286
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compliance.  The safety of the person administering the medicine should also be considered287
(Bennett et al., 2010). An alternative approach to support pet compliance could be training the288
pet to be more favourable to handling and drug administration already as a kitten. In289
medicating cats with chronic illnesses, maintaining compliance is crucial (Jevring, 2005). In290
our data, nearly half of the medications were long-term.291
292
Administration practice varied markedly and owners described several methods for293
avoiding consumption failure. The tablets may have been easier to handle than liquid dosage294
forms, because they (if small enough) could be given inside a treat or with other palatable295
material. Nevertheless, it is known that solid dosage forms given by dry swallowing can296
become trapped in the oesophagus and cause esophagitis or even stricture formation (German297
et al., 2005; Beatty et al., 2006). Therefore, several authors have recommended that solid oral298
dosage forms should be given with a water bolus or a small amount of food to facilitate299
oesophageal clearance, or otherwise with an administration aid such as a pill delivery treat or300
flavoured liquid (Graham et al, 2000; Westfall et al., 2001; Bennett et al., 2010). Furthermore,301
owners facilitated administration by giving the drug mixed in the cat’s food. The food302
approach may, however, be problematic, because the food effects on bioavailability of the303
drug substance or the dosage form performance may not be easily managed (Ahmed and304
Kasraian, 2002).305
306
Our results suggest that the free-choice acceptance and ease of dosage form307
administration are still problematic in feline medication. This often seems to be related to the308
use of off-label drugs. Thus, there is need for pharmaceutical development of solid dosage309
forms for cats in particular. Species-specific considerations are needed, including tablet size310
and formulations that enhance free-choice acceptance and ease in swallowing. Dosage form311
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characteristics, including small tablet size, palatability or tastelessness were preferred by cat312
owners in the present study.313
314
One limitation of the study was the relatively small sample size. Information on a total315
of 46 cats and 67 orally administered drugs was provided in the study. The low survey316
response rate made the study subject to non-response bias, and the results may have led to317
overestimation of the owners’ compliance and abilities to medicate the cat, using oral318
medication formulations. The more compliant owners were more likely to have been319
respondents. As an open e-questionnaire, the survey relied on a convenience sample, which320
may have led to undercoverage of noncompliant owners or owners who have limited access to321
the Internet. The retrospective study setting increased the risk for pet owner recall bias for322
self-reported data.323
324
Conclusion325
Our results confirm that there is need for developing new palatable and easily326
administered drugs for feline medication. Medications registered for feline administration327
were more palatable than off-label drugs, even though the owners reported that their cats took328
the drugs willingly in only 35 % of these cases. To improve the willingness of cats to ingest329
the drugs, as well as owner compliance, the individual nature of the cat should be taken into330
account, and not only effective, but also easily administrable dosage forms should be331
developed for cats.332
333
334
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TABLES
Table 1. Demographic data on cats and their owners (a total of 67 oral medications in 46
cats).
Pedigree cats 25 (54%)
Domestic cats a 21 (46%)
Age of the cat (years) 0.25 to 17 years (average 7.1 years, SD ± 5.1)
Castrated males 23 (50%)
Spayed females 13 (28%)
Intact males 6 (13%)
Intact females 4 (9%)
Number of cats in household median 2.5 (average 3.6, SD ± 2.8, range 1 to 12 cats)
Persons responsible for medicating the cat b
One 28 (61%)
Two 17 (37%)
Three 1 (2%)
All owners reported previous experience in medicating cats (the level of experience was not rated)
a Short hair or long hair domestic cat
b One of which was the owner
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Table 2. Questions concerning the dosage form and administration of medication to the cat.
The type of question is indicated by the letters a, b, c and d.
Specify the dosage form administered to the cat *
How many doses were administered daily? a
How many drugs were administered concurrently? a
If the cat had concurrent medications, what was the total daily administration frequency? a
What was the duration of drug treatment? b
How was the drug given to the cat? b **
Did you use some kind of administration aid in giving the drug to the cat? b ***
Did the cat accept the drug willingly? c
Did the salivation of the cat increase while giving the drug? c
Did the cat begin to gag or vomit during ingestion of the drug? c
Did the drug cause any adverse effects? Which adverse effects? b  ****
Was it easy to follow the medication schedule? c
Did you follow the medication schedule precisely? c
Why was it difficult to follow the medication schedule? d
Was it easy to provide a single dose from the package? c
Was the guidance of the administration device provided in the package adequate and clear? c
Was the use of the administration device easy? c
Did the administration of the drug become easier over time? c
Were you able to give all the doses? c
How many doses were missed? d
When were the doses missed? d
Why could you not give all the doses to the cat? d
What was the major problem related to the drug itself or administering the drug to the cat? d
What kind of dosage form would you prefer in medicating your cat? d
What would you consider to be the easiest method for administering the drug to your cat? d
Did you read the drug description before administering the drug? c
Did you receive enough information about the correct use of the drug? c
What kind of information would you have liked to have more of? d
a  Numeric field
b  Multiple choice question
c  Likert scale (Strongly agree/Agree, Neither agree nor disagree, Disagree/Strongly disagree)
d  Open question
* The drug was picked from a list of names and images of 50 commonly used drugs registered for feline
medication in the European Medicines Agency (EMA). If the drug was not on the list, it was reported in open
question.
** Orally (“dry swallowing”), from a cat’s food bowl mixed with food, inside a treat, crushed, dissolved, other
(please describe how), cat refuses to take the medication
*** Inside a treat, with palatable viscous paste, pill gun, dispensed in a gelatin capsule, other administration aid
(please describe which?), no administration aid was used
**** Diarrhoea, constipation,  nausea, dizziness and/or fatigue, skin symptoms other side effects,  (please
describe which)
Adoptive questioning was used; where appropriate the question was conditionally displayed, based on response
to the previous question. Review of the answers by the respondents (back button) and completeness check by the
system for mandatory items (highlighted) were enabled before the questionnaire was submitted.
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Table 3. Frequency of different types of oral dosage forms (a total of 67 medications in 46
cats).
Tablet/
capsule
Solution/
suspension
Total
n n n (%)
Registered for cats
Registered for dogs
Drugs for human medication (off-label drugs)
Ex tempore drugs
25 a
5 c
23 d
2  f
11 b
0
 1 e
0
36 (54)
5 (7)
24 (36)
2 (3)
Total  n (%) 55 (82%) 12 (18%) 67 (100)
a Axilur 250 mg or 500 mg tabl., Clavubactin 50/12,5 mg or 250/62,5 mg tabl., Drontal 230/20 mg tabl.,
Fortekor 2,5 mg or 5 mg tabl., Medrol vet 4 mg tabl., Perlutex vet 5 mg tabl., Synulox 40 mg, 200 mg or 400 mg
tabl., Xeden 15 mg or 50 mg tabl.
b Amovet 50 mg/mL susp., Metacam 0,5 mg/mL susp., Flubenol 44 mg/mL paste, Mirrix 11,5% paste
c Atopica 25 mg tabl., Barbivet 30 mg tabl., Cerenia 16 mg tabl., Furovet 20 mg tabl., Metacam 1 mg tabl.,
d Anafranil 10 mg tabl., Atarax 25 mg tabl., Clinaxin 75 mg caps., Dexametason 1,5 mg tabl., Dilzem 30 mg
tabl., Disperin 50 mg tabl., Doximycin 100 mg tabl., Norvasc 5 mg tabl., Pepcid 10 mg tabl., Prednisolon 5 mg
tabl., Tenobloc 25 mg tabl., Trikozol 200 mg tabl., Tyrazol 5 mg tabl.
e Primperan 1mg/mL sol.
f Tylosin tabl. (University Pharmacy)
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Table 4. Administration frequency of oral dosage forms and duration of the treatment (a total
of 67 medications in 46 cats). Number of concurrently administered medications (orally
administered and other routes of administration, if any) and subsequent administration
frequency for the cat (n = 46).
One
n (%)
Two
n (%)
Three or more
n (%)
Less than one
n (%)
Administration times per day
for one medication
Medications for one cat
Total administration times per
day for one cat
Duration of drug treatment
Short term (10 days or less)
Long term (more than 10 days)
30 (45)
30 (65)
17 (37)
38 (57)
29 (43)
33 (49)
13 (28)
17 (37)
1 (1.5)
3 (7)
10 (22)a
3 (4.5)
0
2 (4)
a Four, three, one and two cats were medicated three, four, five and six times per a day, respectively
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Table 5. Drug and dosage form as explanations for the question “Did the cat accept the drug
willingly?” (a total of 67 medications in 46 cats).
NA Agree Neither agree
nor disagree
Disagree
n n (%) n (%) n (%)
Drug a Registered for cats 2 12 (35.3) 4 (11.8) 18 (52.9)
Registered for dogs 0 1 (20.0) 0 4 (80.0)
Other 2 2 (8.3) 2 (8.3) 20 (83.3)
Total 4 15 (23.8) 6 (9.5) 42 (66.7)
Drug formulation b Tablet/capsule 4 9 (17.6) 5 (9.8) 37 (72.5)
Solution/suspension 0 6 (50.0) 1 (8.3) 5 (41.7)
Total 4 15 (23.8) 6 (9.5) 42 (66.7)
NA = Not answered
a Statistically significant (P<0.05) when drug registered for cats was compared with other drugs, odds ratio OR
(95% confidence interval CI) 4.947 (1.086 – 22.525).
b Statistically significant (P<0.05) when solution/suspension was compared with tablet/capsule, OR (95% CI)
4.776 (1.072 – 21.274).
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Table 6. Other questions concerning the dosage form and administration schedule (a total of
67 medications in 46 cats).
NA Agree Neither agree
nor disagree
Disagree
n n (%)  n (%) n (%)
Was the owner able to give all the doses? 0 51 (76.1) 0 16 (23.9)
Did the salivation of the cat increase while
giving the drug?
4 22 (34.9) 7 (11.1) 34 (54.0)
Did the cat begin to gag or vomit during
ingestion of the drug?
7 12 (20.0) 3 (5.0) 45 (75)
Was it easy to follow the medication schedule? 0 58 (86.6) 2 (3.0) 7 (10.4)
Did the owner follow the medication schedule
precisely?
0 53 (79.1) 7 (10.4.) 7 (10.4)
NA = Not answered. No statistically significant effects were found when the drug, dosage form, daily
administration times, duration of the medication and adverse effects were tested as explanations for the question.
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Table 7. Questions concerning administration practice (a total of 67 medications in 46 cats).
Dry
swallowing
Mixed
with food
in a bowl
Inside a treat b Crushed or
dissolved c
Other d
How was the drug
given to the cat? a
Did you use some
kind of
administration aid
in giving the drug
to the cat?
36
No aid
8 11
Inside a treat (9)
Palatable
viscous paste (2)
13 15
Pill gun (1)
Syringe (9)
Gelatin capsule (2)
Spoon (1)
a Multiple responses possible, b inside a treat or the tablet was covered with Easypill® or butter, c crushed and
then mixed with food (n = 5), dissolved in water and then mixed with food or given with syringe (n = 8), d other:
some kind of administration aid was used (n = 13), in two cases the drug was consumed as a treat. No answers
were obtained for the category “cat refuses to take the medication”.
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Table 8. Other questions concerning administration practice and administration device (a total
of 67 medications in 46 cats).
NA Agree Neither agree
nor disagree
Disagree
n n (%) n (%) n (%)
Was it easy to provide a correct single dose from
the package?
0 49 (73.1) 1 (1.5) 17 (25.4)
Was the guidance of the administration device
adequate and clear?a
0 39 (58.2) 24 (35.8) 4 (6.0)
Was the use of the administration device easy? a 0 32 (47.8)  31 (46.2) 4 (6.0)
Did the administration of the drug become easier
over time?
0 35 (52.2) 12 (17.9) 20 (29.9)
Did you read the drug description before
administering the drug?
Did you receive enough information about the
correct use of the drug?
0
0
57 (85.0)
59 (88.0)
2 (3.0)
4 (6.0)
8 (12.0)
4 (6.0)
NA = Not answered
a Administration device provided in the drug package was related to solution/suspension formulations (n = 12)
